Hasil Pencarian - Luoyan Ai

  • Menampilkan 1 - 6 hasil dari 6
Perbaiki Hasil
  1. 1
    Cardiovascular Outcomes in the Patients With Colorectal Cancer: A Multi-Registry-Based Cohort Study of 197,699 Cases in the Real World

    Cardiovascular Outcomes in the Patients With Colorectal Cancer: A Multi-Registry-Based Cohort Study of 197,699 Cases in the Real World oleh Shilong Zhang, Yan Wang, Pengfei Zhang, Luoyan Ai, Tianshu Liu, Tianshu Liu

    Diterbitkan 2022-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Degradation efficiencies of 2,4,6-TCP by Fe0-based advanced oxidation processes (AOPs) with common peroxides.

    Degradation efficiencies of 2,4,6-TCP by Fe0-based advanced oxidation processes (AOPs) with common peroxides. oleh Luoyan Ai, Tiancheng Ren, Qin Yan, Mengdan Wan, Yajuan Peng, Xiaoyun Xu, Xinxin Liu

    Diterbitkan 2021-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    TRAPPC4 regulates the intracellular trafficking of PD-L1 and antitumor immunity

    TRAPPC4 regulates the intracellular trafficking of PD-L1 and antitumor immunity oleh Yimeng Ren, Yun Qian, Luoyan Ai, Yile Xie, Yaqi Gao, Ziyan Zhuang, Jinxian Chen, Ying-Xuan Chen, Jing-Yuan Fang

    Diterbitkan 2021-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Nivolumab-associated DRESS in a genetic susceptible individual

    Nivolumab-associated DRESS in a genetic susceptible individual oleh Qian Li, Yimei Wang, Qing Liu, Jie Gao, Tianshu Liu, Duojiao Wu, Luoyan Ai, Yuan Ji, Shihai Zhao, Yue-Hong Cui, Xiaoshi Jin, Jingjie Li, Yiyi Yu

    Diterbitkan 2021-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Heparanase modulates the prognosis and development of BRAF V600E-mutant colorectal cancer by regulating AKT/p27Kip1/Cyclin E2 pathway

    Heparanase modulates the prognosis and development of BRAF V600E-mutant colorectal cancer by regulating AKT/p27Kip1/Cyclin E2 pathway oleh Mengling Liu, Xiaojing Xu, Ke Peng, Pengcong Hou, Yitao Yuan, Suyao Li, Xun Sun, Zhongyi Shi, Jiayu Zhang, Yu Dong, Qing Liu, Luoyan Ai, Li Liang, Lu Gan, Qihong Huang, Yiyi Yu, Tianshu Liu

    Diterbitkan 2022-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Tislelizumab plus cetuximab and irinotecan in refractory microsatellite stable and RAS wild-type metastatic colorectal cancer: a single-arm phase 2 study

    Tislelizumab plus cetuximab and irinotecan in refractory microsatellite stable and RAS wild-type metastatic colorectal cancer: a single-arm phase 2 study oleh Xiaojing Xu, Luoyan Ai, Keshu Hu, Li Liang, Minzhi Lv, Yan Wang, Yuehong Cui, Wei Li, Qian Li, Shan Yu, Yi Feng, Qing Liu, Ying Yang, Jiao Zhang, Fei Xu, Yiyi Yu, Tianshu Liu

    Diterbitkan 2024-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: